The issue is, you kind of have to not get wrecked by the negative impacts to collect those positive impacts.

Unfortunately, "AI that's competent at bioweapon R&D" might be an easier mark to hit than "AI that can put a dent in the aging process". And biorisks can have a very favorable "resource input -> suffering output" rate of returns.